NEW YORK, Sept 20 – Structural Genomix of San Diego, Calif., said Wednesday it raised $45 million in a private equity financing, bringing the amount of money the company has raised this year to $77 million.

BA Venture Partners led the round while Amerindo, MDS Health Ventures, Orbimed Advisors, and Vector Fund Management also invested in Structural Genomix, a company involved in determining protein structures.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.